ACTIVE

VASCULAR RESEARCH NETWORK BVBA

Export PDF

Financial year 2024 · Closed on 31/12/2024

Net result-9,6 k €-6,1 %over 1 year
Equity-158,6 k €-6,4 %over 1 year
Workforce0,0 ETP

Identity

Source · BCE/KBO

VASCULAR RESEARCH NETWORK BVBA is a Private limited company incorporated in 2014. Its registered office is in Leuven.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0564.780.124
Incorporation
16/10/2014
Legal form
Private limited company
Registered office
Grauwmeer 1 box 5
3001 Leuven · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2024
Average workforce
0,0 ETP
Signals
Good liquidity

Financials

Source · NBB, 10 filings

Trend over 10 financial years

20242023202220212020
Income statement
Gross margin–0 €2,5 €8,4 k €22,7 k €
EBITDA–0 €2,5 €8,4 k €22,7 k €
Operating result–0 €2,5 €8,4 k €22,7 k €
Net result-9,6 k €-9 k €-9 k €116,9 €14,5 k €
Balance sheet
Equity-158,6 k €-149 k €-140 k €-130,9 k €-131,1 k €
Total assets45,1 k €45,1 k €45 k €45,7 k €53,9 k €
Cash40,2 k €40,2 k €40,1 k €41,3 k €43,3 k €
Debts152,6 k €152,6 k €152,6 k €153 k €169,1 k €
Other
Workforce0,0 ETP0,0 ETP–––

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 7 ended

Active mandates

Excelya NL ANDERE

Director

Represented by Frederic Pacqueville

Active

Ended mandates

Delta Medical Consultants BV

Manager

Represented by Peter Kastelein

Ended
Excelya Netherlands BV

Director

Represented by Frederic Paqueville

Ended
Excelya NL

Director

Represented by Frederic Pacqueville

Ended
Excelya NL BV

Director

Represented by Frederic Paqueville

Ended

Other companies at this address

Grauwmeer 1 3001 Leuven
CompanyCBE no.
AIRLINE SUPPLY CHAIN SERVICES● Bankrupt
0832.765.784
Auxilium● Active
0793.179.589
BARKERSECO● Bankrupt
0427.909.956
Beams● Active
0775.783.432
CAPEX● Active
0641.679.348
ClimIT● Active
0770.395.675
COMMON GROUND CORPORATE FINANCE● Active
0821.621.771
DEKIMO EXPERTS LEUVEN● Active
0637.904.167
E+DRIVE● Active
0775.781.353
FELVES● Bankrupt
0460.392.880
FOR LEISURE & SPORT● Active
0628.732.818
Fortuna Familia● Active
1001.580.032
Hoydonckx en Partners - Bedrijfsrevisoren - Hoydonckx et Partners - Reviseurs d'Entreprises● Bankrupt
0465.828.642
IMMO HOT-SPOT● Bankrupt
0861.384.348
Jayjays● Active
0686.576.193
JLA+● Active
0801.168.233
JMC PROJECT MANAGEMENT● Active
0870.169.974
KONSILO● Active
0891.542.638
LANTANA● Active
0707.681.514
Le Concert Olympique● Active
0823.845.645

Full financial information

Source · NBB
202420232022202120202019
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/06/202521/10/202431/08/202329/08/202225/05/202125/02/2020
General meeting15/06/202515/06/202415/06/202315/06/202231/03/202119/02/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 10 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202415/06/202530/06/2025EnglishPDF
Abridged model31/12/202315/06/202421/10/2024DutchPDF
Abridged model31/12/202215/06/202331/08/2023DutchPDF
Abridged model31/12/202115/06/202229/08/2022DutchPDF
Abridged model31/12/202031/03/202125/05/2021DutchPDF
Abridged model31/12/201919/02/202025/02/2020DutchPDF
Abridged model31/12/201814/03/201926/03/2019DutchPDF
Abridged model31/12/201715/06/201802/08/2018DutchPDF
Abridged model31/12/201615/06/201730/06/2017DutchPDF
Abridged model31/12/201515/06/201604/07/2016DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 7 ended

Active mandates

Excelya NL ANDERE

Director

Represented by Frederic Pacqueville

Active

Ended mandates

Delta Medical Consultants BV

Manager

Represented by Peter Kastelein

Ended
Excelya Netherlands BV

Director

Represented by Frederic Paqueville

Ended
Excelya NL

Director

Represented by Frederic Pacqueville

Ended
Excelya NL BV

Director

Represented by Frederic Paqueville

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates28/11/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates29/10/2024
    ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates10/08/2020
    ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
    PDF
  • Mandates27/07/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office04/02/2019
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates31/08/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office04/05/2017
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Registered office01/03/2017
    MAATSCHAPPELIJKE ZETEL
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024-9,6 k €↓
  2. 2023
    Annual accounts 2023-9 k €↑
  3. 2023
    Name changeVasculair Research Network, afgekort VRN
  4. 2022
    Annual accounts 2022-9 k €↓
  5. 2021
    Annual accounts 2021116,9 €↓
  6. 2021
    Name changeVasculair Research Network
  7. 2020
    Annual accounts 202014,5 k €↑
  8. 2019
    Annual accounts 2019-31,6 k €↓
  9. 2018
    Annual accounts 2018115,2 k €↑
  10. 2017
    Annual accounts 2017-38,8 k €↑
  11. 2016
    Annual accounts 2016-120,8 k €↓
  12. 2015
    Annual accounts 2015-88,2 k €
  13. 2015
    Name changeVASCULAR RESEARCH NETWORK BVBA
  14. 16/10/2014
    IncorporationPrivate limited company